New York Senate Bill 5352: Requires notification by a prescriber or pharmacist of the substitution of one generic drug product for another generic drug product; requires both oral and written notification.

New York · 2025-2026 session

What it does

Requires notification by a prescriber or pharmacist of the substitution of one generic drug product for another generic drug product; requires both oral and written notification.

Latest action

REFERRED TO HIGHER EDUCATION (2026-01-07)

See how S 5352 affects you on CapitolKey

Browse more bills · CapitolKey home